** Shares of Maryland-based drugmaker Emergent BioSolutions EBS.N rise 11.8% to $5.21
** EBS authorizes the repurchase of up to $50 million of the company's common stock on or before March 27, 2026
** EBS has 54.3 million outstanding shares, with a market capitalization of $253.2 million according to data compiled by LSEG
** As of last close, EBS has risen 84% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.